b
r
c
synthesis
nmethylcdiethoxyphosphorylnitron
narylacrylamid
good
yield
cisand
transisoxazolidin
phosphon
obtain
herein
evalu
activ
broad
rang
dna
rna
virus
none
compound
endow
antivir
activ
subtox
concentr
isoxazolidin
phenyl
substitut
halogen
ar
h
h
h
found
inhibit
prolifer
cem
well
hela
cell
ic
lm
rang
nucleosid
analogu
great
interest
medicin
chemistri
due
broad
spectrum
biolog
activ
extens
search
modifi
nucleosid
led
discoveri
mani
potent
drug
treatment
variou
viral
infect
divers
type
neoplasm
fig
advers
effect
avail
therapi
low
select
observ
drug
resist
becom
drive
forc
search
new
analogu
improv
pharmacokinet
pharmacodynam
properti
numer
modif
natur
occur
nucleosid
provid
analogu
alter
sugar
andor
nucleobas
subunit
heterocycl
contain
one
heteroatom
carbocycl
variou
size
well
straight
branch
chain
also
heteroatom
appli
altern
furanos
ring
far
less
attent
paid
synthesi
analogu
modifi
nucleobas
residu
comparison
sugarmodifi
analogu
due
ensur
base
pair
recent
proven
aromat
ring
abl
basepair
well
long
list
nucleosid
analogu
continu
expand
incorpor
sever
linker
group
carbamoyl
ureidyl
function
among
other
isoxazolidin
framework
success
appli
surrog
furanos
ring
synthesi
nucleosid
analogu
anticanc
antivir
activ
fig
nucleosid
analogu
adfu
fluorouracil
residu
attach
isoxazolidin
ring
induc
apoptosi
lymphoid
monocytoid
cell
exhibit
low
level
cytotox
phosphonyl
isoxazolidin
inhibit
revers
transcriptas
activ
compar
azt
protect
human
peripher
blood
mononuclear
cell
transmiss
furthermor
compound
gener
formula
show
high
cytotox
activ
sever
cancer
cell
line
compar
known
anticanc
drug
name
mitomycin
c
paclitaxel
use
posit
control
synthesi
promis
antiprolif
properti
isoxazolidin
report
bortolini
et
al
recent
seri
isoxazolidin
nucleosid
well
modif
spacer
obtain
antivir
cytotox
properti
evalu
isoxazolidin
substitut
found
cytotox
hela
cell
line
r
ic
mm
respect
cisconfigur
deriv
complet
inhibit
revers
transcriptas
activ
avian
moloney
viru
amv
human
immunodefici
viru
hiv
although
isoxazolidinephospon
show
antivir
activ
subtox
concentr
deriv
unsubstitut
fluorosubstitut
phenyl
ring
prove
slightli
cytostat
encourag
result
new
seri
isoxazolidin
design
scheme
compound
could
regard
nucleotid
prodrug
due
incorpor
bioisoster
diethoxyphosphoryl
function
isoxazolidin
ring
mimic
nucleosid
monophosph
moreov
anticip
insert
carbamoyl
linker
isoxazolidin
moieti
care
select
mono
dior
trisubstitut
phenyl
group
nucleobas
replac
would
improv
interact
within
dnarna
strand
form
stronger
hydrogen
bond
synthesis
desir
isoxazolidin
cycloaddit
nmethyl
cphosphorylnitron
seri
acrylamid
employ
scheme
substitut
acrylamid
use
paper
alreadi
describ
literatur
howev
compound
prepar
accord
standard
procedur
commerci
avail
substitut
anilin
acryloyl
chlorid
presenc
triethylamin
cycloaddit
nitron
acrylamid
carri
toluen
afford
mixtur
diastereoisomer
isoxazolidin
scheme
tabl
case
moder
good
transci
diastereoselect
de
observ
crude
mixtur
respect
cycloadduct
subject
column
chromatographi
almost
case
except
pure
major
transisom
separ
moder
good
yield
tabl
isol
pure
minor
cisisom
cru
cial
biolog
evalu
trivial
task
howev
sever
purif
enrich
diastereoisomer
mixtur
respect
isoxazolidin
silica
gel
column
prove
fruit
isoxazolidin
tabl
make
minut
quantiti
avail
stereochemistri
cycloaddit
nsubstitut
cphosphoryl
nitron
variou
alken
alreadi
describ
rel
configur
transand
cisisoxazolidin
cycloadduct
establish
base
detail
conform
analys
inde
assign
rel
configur
isoxazolidin
often
difficult
due
conform
flexibl
substitut
fivememb
ring
case
isoxazolidin
contain
diethoxyphosphoryl
group
stereochem
valuabl
data
extend
pcch
pccc
vicin
coupl
appear
extrem
use
establish
stereochemistri
phosphoruslabel
heterocycl
major
isom
obtain
isoxazolidin
transconfigur
assign
take
advantag
previou
observ
regard
stereochemistri
cycloaddit
nmethylcphosphoryl
nitron
termin
alken
seri
similar
approach
configur
assign
appli
thu
base
valu
vicin
coupl
constant
j
cccp
hz
j
hz
j
hz
j
hz
j
hz
j
hz
j
hz
extract
h
c
nmr
spectra
compound
prefer
e
conform
isoxazolidin
ring
fig
establish
conform
diethoxyphosphoryl
group
resid
equatori
posit
isoxazolidin
ring
carbamoyl
substitu
locat
pseudoequatori
furthermor
similar
spectral
pattern
previous
observ
structur
relat
methyl
diethoxyphosphoryl
provid
addit
piec
evid
alreadi
establish
rel
configur
isoxazolidin
noe
experi
perform
fig
occurr
noe
signal
notic
spectrum
lack
correl
urtica
dioica
agglutinin
uda
use
refer
compound
antivir
activ
express
ec
compound
concentr
requir
reduc
viru
plaqu
format
vzv
reduc
virusinduc
cytopathogen
virus
unfortun
inhibitori
activ
viru
detect
evalu
compound
lm
cytotox
test
compound
toward
uninfect
host
cell
defin
minimum
compound
concentr
mcc
caus
microscop
detect
alter
normal
cell
morpholog
cytostat
inhibitori
concentr
ic
caus
decreas
cell
prolifer
determin
murin
leukemia
human
lymphocyt
cem
human
cervix
carcinoma
hela
cell
none
test
compound
affect
cell
morpholog
hel
hela
vero
mdck
crfk
cell
concentr
lm
howev
sever
compound
phenyl
residu
substitut
f
br
cl
ch
c
group
abl
inhibit
cell
prolifer
cc
concentr
rang
lm
cell
lm
cem
hela
cell
tabl
structureact
relationship
studi
seri
describ
paper
reveal
gener
cisisom
cytostat
toward
test
tumour
cell
line
respect
vs
vs
vs
vs
vs
vs
cytostat
accord
kool
group
could
regard
uracil
nonpolar
isost
due
steric
electrostat
similar
surpris
introduct
addit
fluorin
atom
aromat
ring
result
loss
cytostat
activ
ar
h
new
seri
effici
obtain
nmethylcdiethoxyphoshporylnitron
respect
narylacrylamid
via
cycloaddit
synthesis
isoxazolidineposphon
evalu
varieti
dna
rna
virus
activ
lm
cytostat
activ
compound
perform
three
tumor
cell
line
cem
hela
show
cisconfigur
isoxazolidin
contain
phenyl
substitut
halogen
ar
h
ar
h
ar
h
activ
toward
test
cancer
cell
line
ic
lm
studi
isoxazolidinephosphon
gener
formula
contain
natur
modifi
nucleobas
instead
aryl
group
progress
publish
due
cours
h
nmr
spectra
taken
cdcl
cd
od
follow
spectromet
varian
bruker
avanc
iii
tabl
inhibitori
effect
sever
prolifer
murin
leukemia
human
tlymphocyt
cem
human
cervix
carcinoma
cell
hela
ar
mhz
tm
intern
standard
start
materi
solvent
dri
accord
literatur
method
nitron
previous
report
gener
procedur
prepar
acrylamid
solut
substitut
anilin
mmol
dichloromethan
ml
triethylamin
mmol
ad
mixtur
cool
ice
bath
acryloyl
chlorid
mmol
ad
dropwis
reaction
mixtur
stir
h
room
temperatur
extract
water
ml
subsequ
inorgan
layer
extract
ethyl
ether
ml
combin
organ
layer
dri
anhydr
mgso
filter
evapor
solvent
residu
purifi
silica
column
chloroform
methanol
mixtur
vv
eluent
afford
respect
acrylamid
mixtur
nitron
mmol
acrylamid
mmol
toluen
ml
stir
h
disappear
start
nitron
evapor
solvent
reduc
pressur
crude
product
purifi
silica
gel
chromatographi
chloroformmethanol
mixtur
eluent
c
nmr
signal
extract
spectrum
mixtur
inhibit
iii
b
rod
induc
cytopath
cem
cell
cultur
measur
microtit
plate
contain
cem
cellsml
infect
ccid
hiv
per
millilit
contain
appropri
dilut
test
compound
day
incub
co
control
humidifi
atmospher
cem
giant
syncytium
cell
format
examin
microscop
ec
effect
concentr
defin
compound
concentr
requir
inhibit
hivinduc
giant
cell
format
assay
perform
microtit
plate
well
ad
tumor
cell
given
amount
test
compound
cell
allow
prolifer
h
murin
leukemia
cell
h
human
lymphocyt
cem
human
cervix
carcinoma
hela
cell
humidifi
co
control
atmospher
end
incub
period
cell
count
coulter
counter
ic
inhibitori
concentr
defin
concentr
compound
inhibit
cell
prolifer
